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Mitochondrial oxidative stress, mitochondrial dysfunction,
or both have been implicated in insulin resistance. However,
disentangling the individual roles of these processes in insulin
resistance has beendifficult because they often occur in tandem,
and tools that selectively increase oxidant production without
impairing mitochondrial respiration have been lacking. Using
the dimer/monomer status of peroxiredoxin isoforms as an
indicator of compartmental hydrogen peroxide burden, we pro-
vide evidence that oxidative stress is localized to mitochondria
in insulin-resistant 3T3-L1 adipocytes and adipose tissue from
mice. To dissociate oxidative stress from impaired oxidative
phosphorylation and study whether mitochondrial oxidative
stress per se can cause insulin resistance, we usedmitochondria-
targeted paraquat (MitoPQ) to generate superoxide within
mitochondria without directly disrupting the respiratory chain.
At<10M,MitoPQ specifically increasedmitochondrial super-
oxide and hydrogen peroxide without altering mitochondrial
respiration in intact cells. Under these conditions, MitoPQ
impaired insulin-stimulated glucose uptake and glucose trans-
porter 4 (GLUT4) translocation to the plasma membrane in
both adipocytes andmyotubes.MitoPQ recapitulatedmany fea-
tures of insulin resistance found in other experimental models,
including increased oxidants in mitochondria but not cytosol; a
more profound effect on glucose transport than on other insu-
lin-regulated processes, such as protein synthesis and lipolysis;
an absence of overt defects in insulin signaling; and defective
insulin- but not AMP-activated protein kinase (AMPK)-reg-
ulated GLUT4 translocation. We conclude that elevated
mitochondrial oxidants rapidly impair insulin-regulated
GLUT4 translocation and significantly contribute to insulin
resistance and that MitoPQ is an ideal tool for studying the
link between mitochondrial oxidative stress and regulated
GLUT4 trafficking.
Insulin lowers blood glucose, in part, by stimulating glucose
uptake into adipose tissue and skeletal muscle. Insulin achieves
this by increasing cell-surface levels of glucose transporter type
4 (GLUT4) via activation of the phosphatidylinositol 3-kinase/
Akt signaling pathway. This process is defective in insulin resis-
tance, a pathophysiological state that is a major risk factor for
the development of type 2 diabetes and other metabolic
diseases.
Insulin resistance in adipocytes and muscle has been
reported to be caused by a number of systemic insults, includ-
ing increased caloric intake, sedentary behavior, hyperinsuline-
mia, glucocorticoids, and inflammation. Although the relation-
ship between these stresses remains unclear, many involve
alteredmitochondrial function, including incomplete fatty acid
oxidation leading to the accumulation of lipid intermediates
like acylcarnitines (1); increased mitochondrial oxidants (2–6);
and dysregulated mitochondrial turnover, fission/fusion (7),
and proteostasis (8–10). Further, other cellular stresses linked
to insulin resistance, including ceramide accumulation, may
also impairmitochondrial function (11), and insulin-sensitizing
drugs, like metformin and berberine, mediate their beneficial
effects by modulating mitochondrial function in a manner that
remains incompletely understood (12, 13).
Many of these studies have shown amajor role formitochon-
dria in the pathogenesis of insulin resistance. However, mito-
chondrial dysfunction per se appears unlikely to be the primary
cause of insulin resistance. Whereas some genetic (14, 15) or
pharmacologic (16) interventions that specifically compromise
mitochondrial function have been shown to cause insulin resis-
tance, other genetic interventions that impair mitochondrial
function actually improvewhole-body insulin action (17, 18). In
contrast to defects in mitochondrial function, an increase in
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mitochondrial oxidants is a more consistent feature of insulin
resistance in vitro (2, 4, 6) and in vivo (3, 5, 6) and in humans (3).
Furthermore, genetic or pharmacologic interventions to detox-
ify superoxide radical anion (O2. ) or hydrogen peroxide (H2O2)
specifically in mitochondria overcome insulin resistance (3–5).
Whereas these studies imply that mitochondrial O2. /H2O2 are
intimately involved in the development of insulin resistance,
it remains unclear whether scavenging such oxidants also
affected mitochondrial function. For example, expression of
mitochondria-targeted catalase in mice has been reported to
improve insulin sensitivity via increased energy expenditure
and fatty oxidation (19, 20). Thus, there is a pressing need to
show a direct link between mitochondrial oxidants and insulin
resistance independently of mitochondrial function.
Investigations into the effects of mitochondrial oxidants on
insulin action have been hampered by a lack of tools to acutely
and specifically induce mitochondrial oxidants without inhib-
iting the mitochondrial electron transport chain (ETC).5
Genetic approaches, such as deletion of mitochondrial super-
oxide dismutase (SOD2), elevate oxidants chronically, which
may lead to compensatory responses (21). Small-molecule
approaches to generate O2. , such as paraquat and antimycin A,
suffer from limitations such as redox cycling in compartments
other than the mitochondria and inhibition of the ETC,
respectively.
To circumvent these limitations, in the present study, we
have used mitochondria-targeted paraquat (MitoPQ), which
enriches in the mitochondrial matrix and generates O2. by
redox cycling at the flavin site of complex I (22). MitoPQ was
reported to increasemitochondrialO2. in culturedmyoblasts, as
assessed by increased hydroethidine-derived fluorescence, and
elicited responses associated with increased mitochondrial O2. ,
such as decreased cell viability (22). We found that MitoPQ
inducedmitochondrial O2. andH2O2 without impairing whole-
cell oxygen consumption. MitoPQ acutely impaired insulin-
stimulated GLUT4 translocation in both adipocytes and mus-
cle cells. This occurredwithout impairment in proximal insulin
signaling toAkt or TBC1D4.MitoPQ caused a specific defect in
insulin regulation of GLUT4 trafficking, and other actions of
insulin remained intact, as has been observed in othermodels of
insulin resistance (23). Thus, treatment with MitoPQ enabled
us to recapitulate previously observed features of insulin resis-
tance. This demonstrates for the first time that an acute
increase in mitochondrial oxidants, independent of mitochon-
drial dysfunction, is sufficient to induce insulin resistance. Our
data in in vitro and in vivomodels of insulin resistance indicate
that oxidative stress in insulin-resistant adipocytes appears spe-
cific tomitochondria, and we propose that thesemitochondrial
oxidants induce a retrograde signaling pathway to impair insu-
lin-regulated delivery of GLUT4 to the PM.
Results
Insulin resistance is associated withmitochondrial oxidative
stress in adipocytes
We have previously reported that multiple in vitromodels of
insulin resistance in cultured adipocytes and myotubes are
associated with increased mitochondrial O2. , as assessed by
hydroethidine-derived fluorescence (4). However, these studies
did not exclude the possibility that there were also increased
oxidants in other cellular compartments, such as the cytosol.
To assess whether insulin resistance is associated with
increased oxidants specifically in mitochondria, we studied the
cytosolic and mitochondrial hydroperoxide burden in two in
vitro models and one in vivo model of adipocyte insulin resis-
tance. Treatment of 3T3-L1 adipocytes with 10 nM insulin for
24 h to mimic hyperinsulinemia or with 2 ng/ml TNF for 96 h
tomimic chronic pro-inflammatory signaling impaired insulin-
stimulated 2-deoxyglucose (2DOG) uptake (Fig. 1, A and B).
Similarly, 14-day high-fat high-sucrose diet (HFHSD) feeding,
which is sufficient to induce maximal adipose tissue insulin
resistance (24, 25), impaired insulin-stimulated 2DOG uptake
into adipose tissue explants (Fig. 1C). We assessed mitochon-
drial and cytosolic relative H2O2 exposure using the dimeric
state of location-specific peroxiredoxins as a surrogate. 2-Cys
PRDXs form disulfide-linked homodimers upon oxidation by
hydroperoxides, such as H2O2, and are slowly reduced to their
5 The abbreviations used are: ETC, electron transport chain; MitoPQ, mito-
chondria-targetedparaquat;MitoPQ-Ctrl,MitoPQ-control; PRDX, peroxire-
doxin; JO2, rate of oxygen consumption; TNF, tumor necrosis factor; 2DOG,
2-deoxyglucose; HFHSD, high-fat high-sucrose diet; JNK, c-Jun N-terminal
kinase; PDGF, platelet-derived growth factor; PDGFR, PDGF receptor;
AICAR, aminoimidazole-4-carboxamide ribonucleotide; AMPK, AMP-acti-
vated protein kinase; HA, hemagglutinin; DMEM, Dulbecco’s modified
Eagle’s medium; KRP, Krebs–Ringer phosphate; RIPA, radioimmune pre-
cipitation assay; NEM, N-ethylmaleimide; MitoSOX, mito-hydroethi-
dine; Mito-E, mito-ethidium; Mito-2OHE, mito-hydroxyethidium; CE,
collision energy.
Figure 1. Adipocyte insulin resistance is associated with increased mitochondrial oxidants. Insulin resistance was induced in 3T3-L1 adipocytes by
treatment with 10 nM insulin (CI) for 24 h (A and D) or 2 ng/ml TNF (TNF) for 96 h (B and D) and in adipose tissue by 14 days of HFHSD feeding (C and E). A–C,
3T3-L1 adipocytes (A and B) and adipose tissue explants (C) were serum-starved for 2 h and assayed for 2DOG uptake following incubation without (basal) or
with insulin (100 nM (A and B) or 10 nM (C)) for 20min (n 3 (A), n 4 (B), and n 5 (C), mean S.E. (error bars), two-sample t test; *, p 0.05).D and E, PRDX2
and -3 dimer/monomer ratios were assessed by immunoblot. Immunoblots were quantified by densitometry and normalized to insulin-sensitive controls
(indicated by the dotted line in D) (n 3–6 (D) and n 4 (E), mean S.E., two-sample t test; *, p 0.05).
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monomer by thioredoxin. Therefore, the PRDX dimer/mono-
mer ratio acts as a surrogate for H2O2 content (26), although
changes in thioredoxin activity and hydroperoxides other than
H2O2 will also contribute. PRDX2 and PRDX3 are localized in
the cytosol andmitochondria, respectively, so thedimer/mono-
mer ratio of these isoforms is indicative of H2O2 content at
these specific locations. The PRDX2 dimer/monomer ratio was
unchanged in all insulin resistance models (Fig. 1, D and E),
indicating that cytosolic peroxide levels were unchanged. In
contrast, the PRDX3 dimer/monomer ratio was increased by
1.8–2.8-fold in in vitromodels (Fig. 1D) and by 2.3-fold in in
vivo models (Fig. 1E). These data suggest that insulin resis-
tance is characterized by an oxidative burden specifically in
mitochondria.
Mitochondria-targeted paraquat elevatesmitochondrial
superoxide and hydrogen peroxide
Mitochondrial oxidants appear to play a causal role in insulin
resistance because pharmacological (4) or genetic (3–5) scav-
enging of these oxidants has been shown to improve insulin
action in adipose and muscle tissue. However, even in these
examples, it is challenging to disentangle mitochondrial oxida-
tive stress from mitochondrial dysfunction, as it is not clear
how scavenging of these oxidants influences mitochondrial
function. To test whethermitochondrial oxidants are sufficient
to cause insulin resistance, we endeavored to establish a system
where we could acutely increase mitochondrial oxidant pro-
duction independently of other changes, such asmitochondrial
dysfunction. To this end, here we describe the use of MitoPQ
(Fig. 2A) (22).
MitoPQ has previously been reported to increase oxidants in
isolated mitochondria and in mitochondria of C2C12 myo-
blasts (22).We testedwhether incubation of 3T3-L1 adipocytes
with MitoPQ increased mitochondrial O2. using LC-MS/MS to
quantify the conversion of mito-hydroethidine to mito-2-hy-
droxyethidium (27), a superoxide-specific product. MitoPQ
increased mito-2-hydroxyethidium concentrations compared
with cells treated with a vehicle control (Fig. 2B), as did a high
dose of paraquat, which was included as a positive control (Fig.
2B). We next tested whether increased mitochondrial O2. was
due to the active paraquat moiety, and not a by-product of, for
example, the triphenylphosphonium lipophilic cation, which
mediates localization to the mitochondria. We tested this by
using an inactiveMitoPQanalogue (MitoPQ-control (MitoPQ-
Ctrl); Fig. 2A), which is localized to mitochondria but does not
generate O2. because the pyridine rings of the viologen compo-
nent are not coplanar and thus cannot stabilize a radical cation
effectively (28). BecauseO2. is rapidly dismutated toH2O2 in the
presence of SOD2, we used PRDX dimerization as a proxy for
subcellular O2. generation. Treatment of 3T3-L1 adipocytes
with MitoPQ for 2 h increased the PRDX2 and PRDX3 dimer/
monomer ratio (Fig. 2, C and D). Although MitoPQ enriches
within the mitochondrial matrix and we expected to detect
increased O2. and resulting H2O2 in the matrix (Fig. 2 (B–D),
PRDX3), we also expected increased cytosolicH2O2 under con-
ditions of high mitochondrial H2O2 due to diffusion of H2O2
frommitochondria (Fig. 2 (C andD), PRDX2).MitoPQ-Ctrl did
not alter the dimerization status of either PRDX2 or -3 (Fig. 2,C
and D), suggesting that MitoPQ-induced changes in the
PRDX3 dimer/monomer ratio were due to redox cycling by the
active paraquat moiety.
We next established the dose of MitoPQ that specifically
induced PRDX3 dimerization without affecting cytosolic
PRDX2 in 3T3-L1 adipocytes treated with MitoPQ for 2 h to
mimic the subcellular oxidative burden in insulin resistance
(Fig. 1). 10 M MitoPQ increased PRDX3 dimer/monomer
ratio in adipocyteswithout a change in PRDX2 (Fig. 2,C andD).
As a control, we included antimycin A, which is an inhibitor of
complex III that increasesO2. production (29) and induces insu-
lin resistance (4). Antimycin A increased PRDX3 dimerization
in 3T3-L1 adipocytes (Fig. 2, C and D) but also increased
PRDX2 dimerization, albeit to a lesser extent (Fig. 2, C and D).
Thus,MitoPQmimicked antimycin A by increasingmitochon-
drial O2. and H2O2 (hereafter referred to collectively as mito-
chondrial oxidants).
Mitochondria-targeted paraquat does not alter whole-cell
respiration
A potential major advantage of using MitoPQ over alterna-
tive small molecules, such as antimycin A, that increase mito-
chondrial oxidants by inhibiting the ETC is that it may be pos-
sible to disentangle the role of mitochondrial oxidants from
mitochondrial dysfunction in insulin resistance. To assess
whether MitoPQ could increase mitochondrial oxidants with-
out affecting mitochondrial function, we monitored oxygen
consumption rates in 3T3-L1 adipocytes.MitoPQdid not affect
oxygen consumption in adipocytes at any dose tested, whereas
50 nM antimycin A inhibited mitochondrial respiration (Fig.
2E). To further test whether we could detect any impairment in
mitochondrial respiration with MitoPQ, we pretreated adi-
pocytes with MitoPQ for 90 min and assessed basal and maxi-
mal respiratory rates in galactose instead of glucose to force
ATP production via mitochondria (30). Under these condi-
tions, 10 M MitoPQ still did not affect basal or uncoupled/
maximal respiratory rates (Fig. 2F), indicating that we were not
impairing mitochondrial respiration.
We next extended our oxidant and bioenergetic analyses to
the L6 skeletal muscle cell line. L6 myotubes were more sensi-
tive to MitoPQ than adipocytes (Fig. 2G), so that MitoPQ
increased PRDX3 dimerization in L6 myotubes at 0.5 M
MitoPQ (Fig. 2G, right), and the PRDX2 dimer/monomer ratio
was unaffected by MitoPQ at doses up to 10 M (Fig. 2G, left).
Antimycin A increased both PRDX2 and PRDX3 dimerization
(Fig. 2G). As in adipocytes, MitoPQ did not impair basal or
maximal respiration of myotubes (Fig. 2H). Together, these
data show that MitoPQ specifically increased mitochondrial
oxidants in 3T3-L1 adipocytes and L6 myotubes without
increasing cytosolic oxidants or impairing respiratory function
or capacity.
Mitochondria-targeted paraquat inhibits insulin-stimulated
GLUT4 translocation
We next tested whether MitoPQ could induce insulin resis-
tance in cultured adipocytes and myotubes. Because 10 M
MitoPQ recapitulated the mitochondria-specific increase in
oxidants in insulin resistance models and this dose of MitoPQ
Mitochondrial oxidants cause insulin resistance
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did not interfere with whole-cell respiration (Fig. 2, E and F) in
adipocytes, we used this dose of MitoPQ to assess the effect of
increased mitochondrial oxidants on insulin-regulated glucose
transport. Treatment of adipocytes for 2 h with 10 MMitoPQ
inhibited insulin-stimulated 2DOGuptake by 26%, and a higher
dose of MitoPQ (25 M) had no additional effect (Fig. 3A). In
contrast, MitoPQ-Ctrl did not affect insulin-stimulated 2DOG
uptake (Fig. 3A), suggesting that impaired insulin action was a
consequence of MitoPQ-induced mitochondrial oxidants. We
next tested various aspects of insulin-stimulated glucose trans-
port to identify the specific process affected byMitoPQ. Insulin
stimulates glucose uptake via the glucose transporter GLUT4.
Mitochondrial oxidants cause insulin resistance
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Expression of GLUT4 in adipocytes was unchanged byMitoPQ
treatment (Fig. 3B), suggesting thatMitoPQmight impair insu-
lin-stimulated GLUT4 translocation to the plasma membrane.
To test this, we assayed cell-surface GLUT4 content using two
complementary GLUT4 reporter constructs: hemagglutinin
(HA)-GLUT4 and pHluorin-GLUT4 in fixed-cell and live-cell
assays, respectively. These constructs weremodified within the
primary exofacial loop of GLUT4 to permit assessment of
GLUT4 plasma membrane content through the accessibility of
theHAepitope in nonpermeabilized cells (Fig. 3C) or due to the
increase in fluorescence of pHluorin when exposed to pH 7.4 of
the extracellular buffer in live-cell assays (Fig. 3D). In the fixed-
cell assay, insulin augmentedHA-GLUT4PM levels by 4.5-fold,
and this was inhibited by 26% in the presence of 10MMitoPQ
(Fig. 3C). Live imaging of pHluorin-GLUT4 trafficking revealed
that both 3 and 10 M MitoPQ impaired insulin-stimulated
GLUT4 exocytosis to the plasmamembrane (Fig. 3D). We next
tested the effect of MitoPQ on insulin responses in primary
adipose explants. As in cultured cells (Fig. 2), MitoPQ (25 and
50 M) increased the PRDX3 dimer/monomer ratio without
altering that of PRDX2 (Fig. 3E), indicative of oxidant produc-
tion inmitochondria. Incubation with 25MMitoPQ impaired
insulin-stimulated 2DOG uptake in adipose explants (Fig. 3F).
As in adipocytes and adipose tissue, MitoPQ induced insulin
resistance in L6myotubes as measured by HA-GLUT4 translo-
cation (Fig. 3G) at doses that selectively increased oxidants in
themitochondria but not in the cytosol and that had no detect-
able effect on mitochondrial respiration (Fig. 2, G and H). The
degree of insulin resistance was similar at 0.5 and 1MMitoPQ
and at higher doses (data not shown). This was specific to
MitoPQ with an active paraquat moiety because the MitoPQ-
Ctrl had no effect (Fig. 3G). We also tested whether MitoPQ
could impair GLUT4 translocation more acutely in L6 myo-
tubes to test whether more acute induction of mitochondrial
oxidants could cause insulin resistance. Incubation with 1 M
MitoPQ for 30 min increased the PRDX3 dimer/monomer
ratio to a similar extent as measured after a 2-h incubation
(Figs. 2G and 3H), and this was accompanied by impaired
insulin-stimulated HA-GLUT4 translocation (Fig. 3G). We
extended our work in muscle to isolated soleus to determine
whether specific induction of mitochondrial oxidants with
MitoPQ also caused insulin resistance in primary muscle prep-
arations (Fig. 3, I and J). Here, using a dose of MitoPQ that
specifically increased PRDX3 dimerization (25 M), we also
observed impaired insulin-stimulated 2DOG uptake (Fig. 3J).
Together, these data show thatMitoPQ acutely impairs insu-
lin-stimulated glucose uptake by blocking GLUT4 trafficking,
supporting a role for mitochondrial oxidants, independent of
mitochondrial function, in the induction of insulin resistance in
adipose and muscle tissue.
Mitochondria-targeted paraquat induces insulin resistance
without defects in canonical insulin signaling
Impaired insulin signaling through IRS1 to Akt is often
observed in insulin resistance (31, 32) and has been hypothe-
sized to be upstream of defects in GLUT4 translocation.
Indeed, it has been proposed thatmitochondrial oxidants cause
insulin resistance through the activation of stress kinases, such
as c-Jun N-terminal kinases (JNKs), and subsequent phosphor-
ylation and down-regulation of IRS1 (33, 34). We next directly
testedtherequirementforIRS1inMitoPQ-inducedinsulinresis-
tance in adipocytes and L6 myotubes. To achieve this, we uti-
lized 3T3-L1 adipocytes ectopically expressing platelet-derived
growth factor receptor (PDGFR). This is a useful system
because PDGF stimulates Akt phosphorylation and GLUT4
translocation in a manner similar to insulin but independently
of IRS1 (35). MitoPQ inhibited both insulin- and PDGF-stimu-
lated GLUT4 translocation (Fig. 4A), indicating that IRS1 is not
the target of the mitochondrial oxidant-induced defect in
GLUT4 translocation. The same phenomenon was observed in
L6 myotubes (Fig. 4B).
These data implicated events downstream of IRS1 in
MitoPQ-induced insulin resistance. We next tested whether
insulin signaling to Akt or the Akt substrate most associated
withGLUT4 translocation, TBC1D4, was defective inMitoPQ-
treated cells. In both 3T3-L1 adipocytes and L6myotubes, insu-
lin treatment increased phosphorylation of Akt at activating
sites and of TBC1D4 at Thr-642 (Fig. 4C). Insulin signaling to
these sites was not affected by 10 or 25MMitoPQ in either cell
line (Fig. 4C). Therefore, impaired insulin-stimulated 2DOG
uptake or GLUT4 translocation in response to MitoPQ in
3T3-L1 adipocytes (Fig. 3, A and C), adipose explants (Fig. 3F),
and L6 myotubes (Fig. 3G) occurred without any detectable
defect in the major signaling proteins thought to regulate
GLUT4 trafficking in response to insulin. These data, in com-
bination with the lack of a consistent signaling defect in in vivo
and in vitro models of adipocyte insulin resistance (Fig. 4D),
support previous reports indicating that it is unlikely that insu-
lin resistance is due to a defect in proximal components of the
insulin signaling pathway (24, 35–37).
Figure 2. Mitochondria-targeted paraquat increases mitochondrial superoxide and hydrogen peroxide without inhibiting cellular respiration. A,
chemical structures of MitoPQ (mPQ) and an inactive analogueMitoPQ-Ctrl (mPQ-Ctrl) used in this study. B, concentration of 2-hydroxyethidium derivative of
MitoSox relative to all products of MitoSOX in cells treated with 25 M MitoPQ or 5 mM paraquat (PQ) for 2 h as indicated (n  4, mean  S.E. (error bars),
two-sample t test corrected formultiple comparisons; *,p0.05 versusDMSO-treatedcells).CandD, PRDX2and -3dimer/monomer ratios in3T3-L1adipocytes
treated with DMSO, 25 M MitoPQ-Ctrl, or MitoPQ (C, top) or increasing doses of MitoPQ (C, bottom) were assessed by immunoblotting. Immunoblots were
quantified by densitometry andnormalized toDMSO-treated cells (D) (indicatedby the dotted line) (PRDX2, n 3–5; PRDX3, n 3–6;mean S.E., one-sample
t test; *, p 0.05). E, oxygen consumption wasmeasured in 3T3-L1 adipocytes cultured in glucose-containingmedium.Dotted lines on the trace (left) indicate
the time drugs were added. Stable rates of oxygen consumption (JO2) were compared between conditions (n 4–5, mean S.E., two-sample t test corrected
formultiple comparisons; *, p 0.05). F, oxygen consumptionwasmeasured in 3T3-L1 adipocytes in galactose-containingmedium. Following basalmeasure-
ments, cells were sequentially treated with oligomycin (Oligo), BAM15 (uncoupler), and rotenone/antimycin A (Rot/AA) (n 3, mean S.E., two-sample t test
corrected for multiple comparisons). G, PRDX2 and -3 dimer/monomer ratios were assessed in L6 myotubes treated as indicated by immunoblotting. Immu-
noblotswerequantifiedbydensitometry andnormalized tountreated cells (indicatedby thedotted line) (PRDX2,n4; PRDX3,n4;mean S.E., one-sample
t test; *, p 0.05). H, oxygen consumption was measured in L6 myotubes in glucose-containing medium. Following basal measurements, cells were sequen-
tially treated with, oligomycin, BAM15, and rotenone/antimycin A (n 3, mean S.E., two-sample t test corrected for multiple comparisons).
Mitochondrial oxidants cause insulin resistance
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Mitochondria-targeted paraquat selectively inhibits
insulin-stimulated glucose transport
We next determined whether the effects of MitoPQ on
GLUT4 translocation were specific to insulin. Previously, it has
been shown that exercise- or AMPK-induced GLUT4 translo-
cation in muscle is not impaired in insulin resistance (38–40).
Thus, we assessed the effects of MitoPQ on AMPK-stimulated
GLUT4 translocation in L6 myotubes. Treatment of L6 myo-
tubeswith theAMPKagonists aminoimidazole-4-carboxamide
ribonucleotide (AICAR) and A-769662 increased cell-surface
Figure 3. Mitochondria-targeted paraquat induces insulin resistance. A, 3T3-L1 adipocytes were assayed for 2DOG uptake following treatment with
DMSO, MitoPQ-Ctrl, or MitoPQ at specified doses for 2 h and incubated without (basal) or with 100 nM insulin for 20 min (n 3–4, mean S.E. (error bars),
two-sample t test corrected for multiple comparisons; *, p  0.05 versus insulin-stimulated DMSO control). B, GLUT4 levels were assessed by immunoblot.
Immunoblotswere quantifiedbydensitometry and expressed relative toDMSO-treated cells (indicatedby adotted line) (n 4,mean S.E., one-sample t test).
C, 3T3-L1 adipocytes expressing HA-GLUT4 were treated as indicated and assessed for plasma membrane–localized HA-GLUT4 with and without insulin
stimulation (n  3–5, mean  S.E., two-sample t test corrected for multiple comparisons; *, p  0.05 versus insulin-stimulated DMSO control). D, 3T3-L1
adipocytes expressing pHlourin-GLUT4 were treated as indicated and assessed for plasma membrane–localized pHlourin-GLUT4 by live-cell total internal
fluorescence microscopy as described under “Experimental procedures” (n  35 cells/condition from two biological replicates, mean  S.E.). E, epididymal
adipose explants were incubated with MitoPQ at the indicated doses for 2 h, and PRDX2 and -3 dimer/monomer ratios were assessed by immunoblotting.
Immunoblots were quantified by densitometry and normalized to DMSO-treated explants (n  3–4, mean  S.E., two-sample t test corrected for multiple
comparisons; *, p 0.05 versus DMSO control). F, adipose tissue explants were incubated for 2 h in the presence of DMSO or 25 M MitoPQ and assayed for
2DOG uptake following incubation without (basal) or with 10 nM insulin for 20min (n 5, mean S.E., two-sample t test; *, p 0.05 versus insulin-stimulated
DMSO control). G, L6 myotubes expressing HA-GLUT4 were treated with DMSO, MitoPQ-Ctrl, or MitoPQ at the specified doses, and insulin responses were
assessed by determining plasma membrane–localized HA-GLUT4 (n  3–5, mean  S.E., two-sample t test corrected for multiple comparisons; *, p  0.05
versus insulin-stimulated DMSO control). Incubation times with MitoPQ were as indicated. H, PRDX2 and -3 dimer/monomer ratios were assessed in L6
myotubes treated with DMSO or MitoPQ for 30 min by immunoblot. Immunoblots were quantified by densitometry and normalized to untreated cells
(indicated by the dotted line) (n 5,mean S.E., one-sample t test; *, p 0.05). I, isolated soleusmuscle was incubatedwith DMSO orMitoPQ at the indicated
doses for 1 h, and PRDX2 and -3 dimer/monomer ratios were assessed by immunoblotting. Immunoblots were quantified by densitometry and normalized to
DMSO-treatedmuscle (n 3–4, mean S.E., two-sample t test corrected formultiple comparisons; *, p 0.05 versusDMSO control). J, isolated soleusmuscle
was incubated for 1 h in the presence of DMSO or 25 M MitoPQ and assayed for 2DOG uptake following incubation without (basal) or with 10 nM insulin for
20 min (n 5–6, mean S.E., two-sample t test; *, p 0.05 versus insulin-stimulated DMSO control).
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HA-GLUT4 to a similar extent as observed with insulin (Fig.
4B). However, in contrast to that seenwith insulin,MitoPQhad
no significant effect on AMPK-induced GLUT4 translocation
in L6 myotubes. Therefore, the defects in insulin-stimulated
GLUT4 translocation in MitoPQ-treated cells and in insulin
resistance models appear to be specific to insulin action. Fur-
thermore, the absence of any defect in AMPK-stimulated
GLUT4 trafficking provides a further similarity between
MitoPQ-induced insulin resistance and most other models
described previously (38–40).
We next investigated the effects of MitoPQ on other insulin-
regulated processes, as insulin resistance has been reported to be
somewhat selective (23, 41). In contrast to its effects on glucose
uptake and GLUT4 trafficking, MitoPQ had no significant effect
on insulin-stimulated protein synthesis or insulin-dependent reg-
ulation of lipolysis in adipocytes at 100 nM insulin (Fig. 4, E and F).
Therefore, consistent with other physiological models of insulin
resistance, such as the diet-induced obese mouse, insulin-stimu-
latedGLUT4translocationwassensitivetoMitoPQunderconditions
where other insulin/Akt-regulated processeswere unaffected.
Figure 4. Mitochondria-targeted paraquat induces insulin resistance downstream of Akt. A and B, 3T3-L1 adipocytes (A) or L6 myotubes (B)
overexpressing HA-GLUT4 and PDGFR were serum-starved, treated with DMSO or the indicated doses of MitoPQ (mPQ) for 2 h, and assessed for plasma
membrane–localized HA-GLUT4 following incubation without (basal) or with 100 nM insulin, 20 ng/ml PDGF, or 2mM AICAR and 100M A-769662 (A769)
for 20 min where indicated (n 4, mean S.E. (error bars), two-sample t test corrected for multiple comparisons; *, p 0.05; comparisons as indicated).
C, 3T3-L1 adipocytes (left) and L6myotubes (right) were serum-starved and treatedwith DMSOor the indicated doses ofMitoPQ for 2 h and insulinwhere
indicated. Phosphorylation status of indicated sites was assessed by immunoblot. Immunoblots were quantified by densitometry and normalized to
insulin-treated control cells (indicated by the dotted line) (n 4, mean S.E., one-sample t test; *, p 0.05). D, insulin resistance was induced in 3T3-L1
adipocytes by treatment with 10 nM insulin (CI) for 24 h or 2 ng/ml TNF (TNF) for 96 h and in adipose tissue by 14-day HFHSD feeding. 3T3-L1 adipocytes
or adipose tissue explants were serum-starved for 2 h and incubated without or with 100 nM insulin for 20 min. Phosphorylation status of the indicated
sites was assessed by immunoblotting. Immunoblots were quantified by densitometry and normalized to insulin-treated control cells (indicated by the
dotted line) (insulin and TNF, n  3; HFHSD, n  6; mean  S.E., one-sample t test; *, p  0.05). E and F, 3T3-L1 adipocytes were serum-starved and
treated with DMSO or the indicated doses of MitoPQ for 2 h, and protein synthesis was assessed by incorporation of [3H]leucine into protein in the
presence and absence of 100 nM insulin (n  4, mean  S.E., two-sample t test corrected for multiple comparisons) (E), or lipolysis was assessed via
release of glycerol into culture medium after stimulation with 1 nM isoproterenol with and without incubation with 100 nM insulin (n 4, mean S.E.,
two-sample t test corrected for multiple comparisons) (F).
Mitochondrial oxidants cause insulin resistance
J. Biol. Chem. (2018) 293(19) 7315–7328 7321
 at G
lasgow
 U
niversity Library on O
ctober 22, 2018
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Discussion
It has been reported previously that mitochondrial oxidants
cause insulin resistance, but a method to specifically induce
oxidants at this site without affectingmitochondrial respiration
has been lacking. In this study, we have obtained three novel
insights into the role of superoxide and oxidative stress in insu-
lin resistance. First, using assessment of the oligomeric state of
compartment-specific PRDXs,we provide compelling evidence
that insulin resistance is associated with a specific increase in
mitochondrial hydroperoxides. Second, we show that MitoPQ,
which selectively induces mitochondrial oxidants (O2. /H2O2)
without inhibiting mitochondria respiration, rapidly induces
insulin resistance. Third, we observed insulin resistance in
response to MitoPQ, as measured by defective insulin-stimu-
lated 2DOG uptake and GLUT4 translocation in cultured cells
and in tissue without any demonstrable defect in proximal
components of the insulin signaling pathway. Insulin resistance
caused by MitoPQ resembled the mode of insulin resistance
seen in many other models, including its relative specificity for
glucose uptake over other insulin-regulated processes and its
selectivity for insulin-regulated glucose uptake, as it had no
significant impact on the ability of other agonists, such as
AICAR. These findings provide support for the induction of an
acute retrograde pathway from mitochondrial oxidants that
converges upon the insulin-responsive GLUT4 machinery in
cytosol in a highly selective manner (Fig. 5).
One challenge in studying insulin resistance is that most
insults that lead to insulin resistance have amultitude of effects,
making it difficult to delineate causal factors. For example, cel-
lular stresses associated with insulin resistance, such as
increased ceramides and endoplasmic reticulum stress, which
have been reported to independently cause insulin resistance,
also induce mitochondrial oxidative stress (11, 42). The inter-
connectivity of these stresses and wide-ranging transcriptional
changes often associated with insults that induce insulin resis-
tance (43) makes it difficult to pinpoint the major causes of
insulin resistance in each case. There is accumulating evidence
that oxidants are elevated in insulin resistance (44) and that
these oxidants originate frommitochondria (2–5). Using PRDX
dimerization as a readout, we report that increased mitochon-
drial H2O2, in the absence of cytosolic H2O2, is a common fea-
ture of three distinct models of adipocyte insulin resistance. It
should be noted that PRDXs can react with other hydroperox-
ides, such as lipid and protein hydroperoxides, so we also can-
not exclude a role for these oxidants in insulin resistance. Here
we report that acute increases in mitochondrial oxidants via
MitoPQ are sufficient to drive insulin resistance in cultured
adipocytes andmyotubes and in adipose tissue and soleusmus-
cle ex vivo. This supports data from transgenic mouse models,
which show that enhanced scavenging ofmitochondrial O2. (via
SOD2) orH2O2 (viamitochondria-targeted catalase or PRDX3)
improved insulin action (3–5) or glucose tolerance (45).
Together, these data suggest that mitochondrial oxidants are
necessary and sufficient to induce insulin resistance in adi-
pocyte andmuscle cells, although there remains conflicting evi-
dence as to the relative contribution and roles of O2. and H2O2
(4, 46).
We have been interested inmitochondrial oxidants and their
role in insulin resistance for some time, yet many perturbations
used previously have a range of potential off-target effects.
Small molecules that increase O2. production in mitochondria
often block the electron transport chain, which could have
many off-target effects. For example, we have previously used
antimycin A to induce O2. and insulin resistance in an oxidant-
dependent manner (4), but this compound acts by impairing
mitochondrial respiration. Genetic models, including knock-
out of oxidant scavenging systems in the mitochondria such, as
SOD2 or PRDX3, or expression of mitochondria-targeted cat-
alase, tend to be longer term andmay be associated with adapt-
ive responses (e.g. mitochondrial function) that can modulate
insulin sensitivity (20, 21). Thus, there has been an enormous
demand for more precise strategies to perturb mitochondrial
oxidant homeostasis without generating off-target effects, such
as inhibiting mitochondrial function. The generation of
MitoPQ was a major breakthrough because it offers a means to
acutely increase mitochondria O2. content without directly
impairing mitochondrial respiration. In the current study, we
comprehensively analyzed the effect of MitoPQ on insulin
Figure 5. Mitochondrial oxidants induces selective insulin resistance. MitoPQ generates oxidants (O2
. and H2O2; denoted by O2
. ) in the mitochondrial
matrix without impairing oxidative phosphorylation. Mitochondrial oxidants inhibit insulin-stimulated GLUT4 translocation and glucose uptake in adipocytes
and myocytes, but AMPK-stimulated GLUT4 translocation is not impaired. MitoPQ did not impair insulin signaling to TBC1D4 or Akt-mediated activation of
protein synthesis and inhibition of lipolysis, indicating that mitochondrial oxidants impair processes downstream of TBC1D4 phosphorylation in the insulin-
regulated GLUT4 trafficking pathway.
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action in cultured adipocyte andmuscle cells and show that this
agent provides an ideal model system for studying insulin resis-
tance because it selectively generated O2. /H2O2 in mitochon-
dria and not the cytosol without impairing whole-cell respira-
tion in either 3T3-L1 adipocytes or L6 myotubes. Further,
MitoPQ induced insulin resistance in primary adipose and
muscle tissue and recapitulated many of the features of insulin
resistance, including impairment of insulin-regulated glucose
transport independently of defects in insulin signaling without
inhibiting AMPK-induced GLUT4 translocation. Hence, this
provides compelling support to implicate mitochondrial oxi-
dants as a major cause of insulin resistance, and this agent will
provide an invaluable tool for assessing howmitochondrial oxi-
dants affect insulin action in vivo and in other tissues, such as
liver, and for studying the mechanism by which mitochondrial
oxidant stress induces insulin resistance.
Despite the importance of mitochondrial oxidants in insulin
resistance, there are a number of key unanswered questions.
For example, what is the source of increased oxidants in mito-
chondria in insulin resistance?Although there is some evidence
that fatty acid oxidationmay contribute (5), a number of sites of
O2. production in mitochondria have been described (47), and
O2. can be produced in the intramembrane space or the matrix.
However, because MitoPQ, which produces matrix O2. , and
antimycin A, which produces O2. in both the intermembrane
space and matrix (48), both cause insulin resistance, our data
suggest that matrix O2. signals to induce insulin resistance.
However, we cannot rule out a role for O2. produced in the
intermembrane space. Indeed, it has recently been reported
that the site of oxidant production has profound effects on the
biological outcome (49), so it will be important to establish how
oxidants are being produced in insulin resistance to better
inform the development of the most appropriate targeted
therapies.
Another outstanding question is how mitochondrial oxi-
dants signal to cause insulin resistance. The rapid onset of insu-
lin resistance upon treatment with MitoPQ argues for an acute
signalingmechanismbetweenmitochondria and insulin signal-
ing/GLUT4 trafficking and that mitochondrial oxidants are a
distal component in the ontogeny of insulin resistance. One
possibility is that mitochondrial oxidants directly impair insu-
lin action in the cytosol through oxidation of specific proteins.
However, we have no evidence for altered cytosolic H2O2 at the
doses of MitoPQ used to induce insulin resistance or in models
of insulin resistance in adipocytes, although this does not rule
out a role for a localized oxidizing environment around mito-
chondria. Alternatively, a mitochondria-derivedH2O2-respon-
sive signal cascadewas recently reported (50), and this would fit
with previous reports that oxidative stress activation of JNKs
may play a role in insulin resistance (33). However, the pro-
posed mechanism for JNK-mediated insulin resistance via Ser/
Thr hyperphosphorylation of IRS1 (34) is inconsistent with our
data showing that MitoPQ-induced insulin resistance is IRS1-
independent. Reduced Akt and TBC1D4 phosphorylation has
been observed in some models of insulin resistance (6, 31, 32,
35). However, our studies with MitoPQ, where we observed
insulin resistance without defects in Akt/TBC1D4, raise ques-
tions over whether such changes in insulin signaling are the
primary driver of insulin resistance. Indeed, we and others have
reported normal Akt activation in insulin-resistant cells and
tissues (24, 35, 51). Furthermore, insulin-stimulated phosphor-
ylation of Akt is defective in muscle from insulin resistant
humans, but this defect does not translate into defective phos-
phorylation of a range of Akt substrates (52).We propose that if
mitochondrial oxidants impair insulin signaling to GLUT4 (e.g.
via JNKor other oxidant-activated kinases), they probably do so
by targeting processes more specific to insulin regulation of
GLUT4 trafficking (Fig. 4G), and this requires further study.
Finally, because GLUT4 trafficking is highly dynamic, transit-
ing between specialized GLUT4 storage vesicles and the trans-
Golgi network, it may be that mitochondrial oxidants impair
GLUT4 localization to GLUT4 storage vesicles. However,
because AMPK-mediated GLUT4 translocation in L6 myo-
tubes was unaffected by MitoPQ, this model would depend on
insulin andAMPK targeting a distinct pool ofGLUT4 (53), with
the insulin-responsive pool being a specific target of mitochon-
drial signaling.Mitochondria are reported tomake contactwith
numerous organelles, including endosomes, so mitochondria
may directly communicate with GLUT4 trafficking machinery
(e.g. through protein oxidation) via these interactions.
In summary, we have found that the oxidative stress burden
in insulin resistance is specific to mitochondria and that
selectively inducing mitochondrial oxidants independently of
changes in oxidative phosphorylation is sufficient to induce
insulin resistance in adipocytes and muscle cells.
Experimental procedures
Animals
Eight-week-old male C57BL/6J mice were purchased from
the animal resources center (Perth, Australia). The animals
were kept in a temperature-controlled environment (22 1 °C)
on a 12-h light/dark cycle with free access to food and water.
Mice were fed ad libitum for a period of 14 days with a standard
laboratory diet (chow) (13% calories from fat, 22% calories from
protein, and 65% calories from carbohydrate, 3.1 kcal/g; Gor-
don’s Specialty Stock Feeds, Yanderra, Australia) or with a
high-fat high-sucrose diet (47% of calories from fat, 21% calo-
ries from protein, and 32% calories from carbohydrates, 4.7
kcal/g). All experiments were carried out with the approval of
the University of Sydney Animal Ethics Committee, following
guidelines issued by the National Health andMedical Research
Council of Australia.
Cell culture
3T3-L1 fibroblasts obtained from the Howard Green labora-
tory (HarvardMedical School) were cultured and differentiated
into adipocytes as described previously (54). 3T3-L1 adipocytes
were used 8–10 days after initiation of differentiation. L6 myo-
blasts were cultured and differentiated into myotubes as
described previously (53) and used for experiments 4–6 days
after initiation of differentiation. For overexpression of HA-
tagged GLUT4, fibroblasts or myoblasts were infected with
pBABE-derived or pWZL-derived HA-GLUT4 retrovirus, and
infected cells were selected for with puromycin (2 g/ml) or
G-418 (0.8 mg/ml) as appropriate. For overexpression of
PDGFR, fibroblasts were infected with pBABE-derived PDGFR
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retrovirus, and infected cells were selected for with puromycin.
For chronic insulin treatments, adipocytes were incubatedwith
10 nM insulin for 1 day, with medium replenished every 12 h.
For induction of insulin resistance by TNF, adipocytes were
incubated with 2 ng/ml TNF for 96 h with medium replen-
ished every 24 h. For acute insulin treatments, 3T3-L1 adi-
pocytes were serum-starved in DMEM supplemented with
0.2% BSA and Glutamax (basal-DMEM) with the indicated
doses ofMitoPQ (or vehicle control, DMSO) or antimycinA (or
vehicle control, EtOH), for 30min or 2 h, as indicated, followed
by the addition of 100 nM insulin.
Assays in adipose tissue explants
Epididymal fat depots were excised frommice. Fat pads were
immediately transferred to warm DMEM, 2% BSA, 20 mM
HEPES, pH 7.4, and minced into fine pieces. Explants were
washed twice and incubated inDMEM, 2%BSA, 20mMHEPES,
pH 7.4, for 2 h.
For 2DOG uptake, explants were rinsed and incubated in
Krebs–Ringer phosphate (KRP), 2% BSA. Insulin (10 nM) was
added for 20 min, and glucose transport was initiated by the
addition of 3H-labeled 2-deoxyglucose (0.25 Ci/sample, 50
M) ([3H]2DOG) and [14C]mannitol (0.036Ci/sample) for the
final 5min of the assay. Uptakewas terminatedwith three rapid
washes in ice-cold PBS, after which the cells were solubilized in
radioimmune precipitation assay (RIPA) buffer (50 mM Tris-
HCl, pH 7.5, 150 mM NaCl, 1% Triton X-100, 0.5% sodium
deoxycholate, 0.1% SDS, 1 mM EDTA, and 10% glycerol) sup-
plemented with protease inhibitors (Roche Applied Science).
Samples were assessed for radioactivity by liquid scintillation
spectroscopy, and glucose uptake was calculated after correct-
ing the [3H]2DOG counts for extracellular [14C]mannitol
counts and normalized for protein content following a BCA
assay.
For experiments usingMitoPQ, 25MMitoPQor equivalent
volume of vehicle (DMSO) was included during the 2-h incu-
bation period in DMEM, 2% BSA and maintained throughout
subsequent washes and incubation. Also, the 2DOG uptake
assaywas carried out inDMEMwithout glucose, 2%BSA rather
than KRP, 2% BSA. Samples were processed as described above
following termination of 2DOGuptake with three rapid washes
in ice-cold PBS. For Western blot analysis, fat explants were
treatedwith insulin after incubation inDMEM, 2%BSA, 20mm
HEPES, pH 7.4, for 2 h. Signaling was terminated with three
rapid washes in ice-cold PBS, and cells were solubilized in RIPA
buffer supplemented with protease inhibitors (Roche Applied
Science).
2DOG uptake assay in soleusmuscle
[3H]2DOG uptake into isolated soleus muscles was per-
formed as described previously (55). Soleus muscles were
excised, mounted, and preincubated for 1 h at 30 °C in Krebs
Henseleit buffer containing 5.5mMglucose, 2mMpyruvate, and
0.1% BSA (KRH) containing DMSO (vehicle control) or 25 M
MitoPQ for 1 h. KRHwas pregassedwith carbogen (95%O2, 5%
CO2). Glucose uptake was assessed following the addition of
[3H]2DOG (final concentration 0.375 Ci/ml) and [14C]man-
nitol (0.05 Ci/ml) with or without 10 nM insulin or 2 mM
AICAR (Toronto Research Chemicals). After 20 min, muscles
were washed in ice-cold PBS and snap-frozen. Frozen muscles
were incubated in 1 M KOH at 70 °C for 20 min. Tracer content
was quantified by liquid scintillation spectroscopy, and glucose
uptake was calculated after correcting the [3H]2DOG counts
for extracellular [14C]mannitol counts and tissue weight.
Assessment of peroxiredoxin dimerization
Cells, explants, or isolated soleus muscles were washed three
times with ice-cold PBS that was pretreated with 10 g/ml cat-
alase for 1 h. Cells were incubatedwith 100mMN-ethylmaleim-
ide (NEM) in PBS for 10 min on ice to alkylate free cysteines.
Cells and soleus muscles were lysed by sonication in 2% SDS in
PBS-containing protease inhibitors (Roche Applied Science)
and 100 mM NEM. Epididymal adipose explants were lysed by
sonication in in 2 RIPA buffer containing protease inhibitors
and 100 mM NEM. Samples were separated by nonreducing
SDS-PAGE.
Synthesis of MitoPQ-Ctrl andMitoPQ
The structures of MitoPQ and of the MitoPQ-Ctrl com-
pound are shown in Fig. 2A. MitoPQ was synthesized as
described (22). The synthesis and characterization of the
MitoPQ control compound will be described in a future
publication.
Assessment of conversion ofmito-hydroethidine (MitoSOX) to
mito-2-hydroxyethidium
Conversion of MitoSOX to mito-2-hydroxyethidium was
detected by LC/tandem MS (LC-MS/MS) as described previ-
ously (27) with modifications. 3T3-L1 adipocytes were incu-
bated with 5 mM paraquat or 25 M MitoPQ in DMEM/Glut-
MAX without FCS for a total of 2 h, and MitoSOX (Thermo
Scientific) was added to 5 M for the final 60 min. Cells were
scraped in ice-cold ethanol and centrifuged at 17,000 g for 15
min, 4 °C. 5l of supernatant was injected onto anAgilent 1290
UHPLC system connected to an Agilent 6490 triple-quadru-
pole mass spectrometer. Analytes were separated on a 2.6-m
Kinetex XB-C18 100 Å column (50  2.10 mm; Phenomenex)
by gradient elution using mobile phase A (0.1% formic acid in
water) and mobile phase B (0.1% formic acid in acetonitrile) at
0.4ml/min. The gradient consisted of 25%mobile phase B from
0 to 2 min, 25–40% B from 2 to 7 min, 40–90% B from 7 to 8
min, 90% B from 8 to 11 min, and back to 25% B from 11 to 12
min. Flow was then directed into the triple quadrupole mass
spectrometerwith parameters set as follows: gas temperature
290 °C; gas flow 14 liters/min; nebulizer pressure 35 p.s.i.;
sheath gas heater  350 °C; sheath gas flow  11 liters/min;
capillary voltage  3,500 V. Detection of MitoSOX, mito-
ethidium (Mito-E), and mito-hydroxyethidium (Mito-
2OHE) was by multiple-reaction monitoring in positive ion
mode using the above general MS parameters with fragmentor
voltage at 380 V and cell accelerator voltage at 5 V. In each case,
the fragment ions generated by collision-induced dissociation
of the [M H] or the [M 2H] ions were used for quanti-
fication. Multiple-reaction monitoring settings for the target
analytes were as follows (parent ion3 fragment ion):MitoSOX
(m/z 632.23 289) with collision energy (CE) 25 V; Mito-E
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(m/z 315.7 3 289) with CE  25 V; and Mito-2OHE (m/z
323.73 289) with CE 25 V.MitoSOXwas quantified against
authentic commercial standard obtained from Invitrogen,
whereasMito-EandMito-2OHEwerequantifiedagainststan-
dards synthesized fromMitoSOX as described previously (27).
Immunoblotting
Cells werewashed three timeswith ice-cold PBS and homog-
enized in 2% SDS by sonication. Insoluble material was
removed by centrifugation at 21,000 g. Protein concentration
was determined by bicinchoninic acid method (Thermo Scien-
tific). 10 g of protein was resolved by SDS-PAGE and trans-
ferred to PVDF membranes. Membranes were blocked in 5%
skimmilk powder in Tris-buffered saline for 1 h, followed by an
overnight incubation at 4 °C with specific primary antibody
solutions. Antibodies specific for pSer-473Akt, pThr-308AKT,
pThr-642 TBC1D4, andAkt were fromCell Signaling Technol-
ogy; GLUT4 antibody was made in-house; -tubulin antibody
was from Sigma; and 14-3-3 antibody was from Santa Cruz
Biotechnology, Inc. Antibodies specific for PRDX2 were from
Abcam, and PRDX3 antibody was from Abfrontier. Mem-
branes were incubated with an appropriate secondary antibody
for 1 h before signals were detected using ECL (Thermo Scien-
tific or Millipore) on the Chemidoc MP (Bio-Rad). In some
cases, IRDye700- or IRDye800-conjugated secondary antibod-
ies were used and then scanned at the 700- and 800-nm channel
using the Odyssey IR imager. Densitometry analysis of immu-
noblots was performed using ImageJ version 1.47.
2DOG uptake assay in 3T3-L1 adipocytes
2DOG uptake was determined as described previously (56).
3T3-L1 adipocytes in 24-well plates were serum-starved in
basal-DMEM for 2 h with MitoPQ where indicated. Cells were
then washed three times in warm PBS and incubated in KRP
(0.6mMNa2HPO4, 0.4mMNaH2PO4, 120mMNaCl, 6mMKCl,
1 mMCaCl2, 1.2 mMMgSO4, and 12.5mMHepes (pH 7.4)) with
0.2% BSA. [3H]2DOG (PerkinElmer Life Sciences) (0.125 Ci/
well) and 50 M unlabeled 2DOGwere added for 5 min. 2DOG
uptake was terminated with three rapid washes in ice-cold PBS,
after which cells were solubilized in 1% (w/v) Triton X-100 in
PBS on a shaker for 1 h and assessed for radioactivity by scin-
tillation counting using a -scintillation counter. To determine
nonspecific glucose uptake, cells were treated with 25 M
cytochalasin B 30 min before the addition of 2DOG. To mea-
sure insulin-sensitive glucose uptake, cells were stimulated
with 10 nM insulin for 20min, and 2DOGwas added in the final
5 min of insulin stimulation. All data were normalized to pro-
tein content. Each condition was performed in triplicate.
HA-GLUT4 assay
HA-GLUT4 levels at the plasmamembranewere determined
as described previously (54, 57). Briefly, cells were serum-
starved for 2 h in basal-DMEM and stimulated with 100 nM
insulin or 20 ng/ml PDGF for 20min as indicated. Todetermine
the amount of HA-GLUT4 at the plasmamembrane, cells were
fixed but not permeabilized and incubated with anti-HA anti-
body (Covance), followed by 20 g/ml goat anti-mouse Alexa
Fluor 488–conjugated secondary antibody (Life Technologies,
Inc.). To determine the total amount of HA-GLUT4, cells in
separate wells were fixed and permeabilized with 0.1% (w/v)
saponin and stained for HA as above. Fluorescence (excitation
485 nm/emission 520 nm) was measured using a fluorescent
microtiter plate reader (FLUOstar Galaxy, BMG LABTECH).
Live-cell microscopy
Live-cell imaging was performed as described previously
(58). Briefly, at 7 days of post-differentiation, adipocytes were
trypsinized with 5 trypsin/EDTA for 5–10 min at 37 °C,
washed twice with PBS, and resuspended in electroporation
solution (20 mM Hepes, 135 mM KCl, 2 mM MgCl2, 0.5% Ficoll
400, 1% DMSO, 2 mM ATP, and 5 mM GSH, pH 7.6) with 5–20
g of plasmid DNA (pHluorin-GLUT4). Cells were electropo-
rated at 200 mV for 20 ms using an ECM 830 Square Wave
Electroporation System (BTXMolecularDelivery Systems) and
seeded into Matrigel-coated 35-mm glass-bottomed dishes
(Ibidi). Adipocytes were maintained in DMEM supplemented
with 10%FCS and1%GlutaMAXuntil required.Healthy, trans-
fected cells were identified by brightfield and fluorescence
microscopy. 15–25 cells were imaged per experiment per con-
dition. Cells were imaged every 60 s for 10 min before the addi-
tion of MitoPQ and imaged for a further 1.5 h. Insulin was
added to 1 and 100 nM at the indicated times. Cells were ana-
lyzed using custom analysis pipelines written in Fiji (59).
Mitochondrial bioenergetics
On day 7 of differentiation, 3T3-L1 adipocytes were
trypsinized and seeded into Matrigel-coated XFp cell culture
plates. L6 cells were differentiated into myotubes in Matrigel-
coated XFp cell culture plates. For analysis of whole-cell respi-
ration (60), cells were washed with warm PBS and incubated in
phenol red–free DMEM containing 30 mM HEPES, pH 7.4, 10
mM NaHCO3, 1 mM glutamine, and 1 mM GlutaMAX contain-
ing 25mM glucose or 25mM galactose as indicated. The follow-
ing injectionswere used for Fig. 2D: port A,MitoPQ to required
dose, antimycin A to 50 nM, or vehicle control; port B-C, main-
tenance treatment from port A; port D, 10M antimycin A. For
experiments in Fig. 2 (E and H), adipocytes or myotubes were
preincubated with the specific dose of MitoPQ for 90 min. The
following injections were used: port A,maintenance ofMitoPQ
or vehicle control; port B, 10 g/ml oligomycin; port C, 10 M
BAM15 (61); port D, 5 M rotenone and 10 M antimycin A.
Each cycle included 3min ofmixing time, 0min ofwaiting time,
and 2min ofmeasuring time, repeated until a steady JO2 reading
was obtained after each injection. Nonmitochondrial respira-
tion was taken as JO2 following 5 M antimycin A. All resulting
rates were normalized to DNA content, measured using
Hoechst 33248 with a previously described Hoechst-staining
protocol (60).
Lipolysis assay
3T3-L1 adipocytes in 24-well plates were serum-starved in
basal-DMEM for 2 h with MitoPQ where indicated. Cells were
washed three times in warm PBS and incubated in KRP supple-
mentedwith 3.5% free fatty acid BSA (Sigma-Aldrich) and 5mM
glucose for 2 h. Cells were treatedwith orwithout isoproterenol
or insulin for 1 h, as indicated. Aliquots of medium were taken
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to assay for glycerol content using Sigma glycerol reagent
according to manufacturer’s instructions. Cells were washed
with PBS and lysed in 1% (w/v) Triton X-100 in PBS and
assessed for protein concentration. Glycerol release was nor-
malized to cellular protein content. Each sample was assayed in
duplicate, and the average of the duplicates was considered as
one biological replicate.
[3H]Leucine incorporation assay for protein synthesis
3T3-L1 adipocytes in 24-well plates were washed twice and
serum-starved in leucine-free DMEM (Sigma-Aldrich) supple-
mented with 0.2% BSA and 20 mM HEPES, pH 7.4, for 2 h with
MitoPQ where indicated. [3H]Leucine (5 Ci/ml) (PerkinEl-
mer Life Sciences) was added at the same time as the indicated
doses of insulin for 1 h. To determine background leucine
incorporation, 5Mcycloheximidewas added for 10min before
the addition of [3H]leucine. Leucine incorporation was termi-
natedwith three rapid washes in ice-cold PBS followed by incu-
bating cells with ice-cold 10% TCA for 10 min to precipitate
protein. Pellets were washed three times in ice-cold 10% TCA
to remove free [3H]leucine. Pellets were resuspended in 50 mM
NaOHwith 1% Triton X-100 at 65 °C for 20min. Samples were
assessed for radioactivity, and results were normalized for pro-
tein content. Assays were performed in triplicate, and the aver-
age of the triplicate was considered as one biological replicate.
General statistical analysis
Data are expressed as means S.E. Specified statistical tests
were performed using GraphPad Prism version 6.01 for Win-
dows (GraphPad Software). For data sets with multiple treat-
ments, subgroups were initially compared with the relevant
analysis of variance, depending on the levels of treatments. If
row or column factorswere significant, specific subgroupswere
then compared using Student’s two-sample t test (adjusting for
multiple comparisons using the Sidak method where indi-
cated). One-sample t tests were used to test significance where
described. Significant effects were defined as p 0.05 by these
t tests, as reported in the figures.
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